BioLargo Basic Shares Outstanding 2010-2025 | BLGO
BioLargo basic shares outstanding from 2010 to 2025. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
BioLargo Annual Basic Shares Outstanding
(Millions of US $) |
| 2024 |
$298 |
| 2023 |
$286 |
| 2022 |
$268 |
| 2021 |
$247 |
| 2020 |
$196 |
| 2019 |
$152 |
| 2018 |
$122 |
| 2017 |
$99 |
| 2016 |
$88 |
| 2015 |
$84 |
| 2014 |
$80 |
| 2013 |
$73 |
| 2012 |
$64 |
| 2011 |
$56 |
| 2010 |
$46 |
| 2009 |
$43 |
BioLargo Quarterly Basic Shares Outstanding
(Millions of US $) |
| 2025-03-31 |
$301 |
| 2024-12-31 |
$298 |
| 2024-09-30 |
$300 |
| 2024-06-30 |
$296 |
| 2024-03-31 |
$294 |
| 2023-12-31 |
$286 |
| 2023-09-30 |
$288 |
| 2023-06-30 |
$285 |
| 2023-03-31 |
$281 |
| 2022-12-31 |
$268 |
| 2022-09-30 |
$271 |
| 2022-06-30 |
$266 |
| 2022-03-31 |
$261 |
| 2021-12-31 |
$247 |
| 2021-09-30 |
$253 |
| 2021-06-30 |
$244 |
| 2021-03-31 |
$234 |
| 2020-12-31 |
$196 |
| 2020-09-30 |
$210 |
| 2020-06-30 |
$182 |
| 2020-03-31 |
$169 |
| 2019-12-31 |
$152 |
| 2019-09-30 |
$156 |
| 2019-06-30 |
$146 |
| 2019-03-31 |
$142 |
| 2018-12-31 |
$122 |
| 2018-09-30 |
$130 |
| 2018-06-30 |
$119 |
| 2018-03-31 |
$105 |
| 2017-12-31 |
$99 |
| 2017-09-30 |
$101 |
| 2017-06-30 |
$98 |
| 2017-03-31 |
$94 |
| 2016-12-31 |
$88 |
| 2016-09-30 |
$88 |
| 2016-06-30 |
$86 |
| 2016-03-31 |
$86 |
| 2015-12-31 |
$84 |
| 2015-09-30 |
$84 |
| 2015-06-30 |
$83 |
| 2015-03-31 |
$83 |
| 2014-12-31 |
$80 |
| 2014-09-30 |
$81 |
| 2014-06-30 |
$77 |
| 2014-03-31 |
$76 |
| 2013-12-31 |
$73 |
| 2013-09-30 |
$73 |
| 2013-06-30 |
$73 |
| 2013-03-31 |
$71 |
| 2012-12-31 |
$64 |
| 2012-09-30 |
$65 |
| 2012-06-30 |
$63 |
| 2012-03-31 |
$60 |
| 2011-12-31 |
$56 |
| 2011-09-30 |
$56 |
| 2011-06-30 |
$55 |
| 2011-03-31 |
$53 |
| 2010-12-31 |
$46 |
| 2010-09-30 |
$44 |
| 2010-06-30 |
$44 |
| 2010-03-31 |
$44 |
| 2009-12-31 |
$43 |
| 2009-09-30 |
$43 |
| 2009-06-30 |
$42 |
| 2009-03-31 |
$42 |
| Sector |
Industry |
Market Cap |
Revenue |
| Construction |
Engineering - Research & Development Services |
$0.065B |
$0.018B |
|
BioLargo Inc. is a cleantech and life sciences innovator and engineering services solution provider. The company's core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs. BioLargo Inc. is based in WESTMINSTER, CA.
|
